vs
富兰克林柯维（FC）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
富兰克林柯维的季度营收约是STEM, INC.的1.4倍（$64.0M vs $47.1M），富兰克林柯维净利率更高（-5.1% vs -33.9%，领先28.8%），富兰克林柯维同比增速更快（-7.3% vs -15.6%），过去两年STEM, INC.的营收复合增速更高（36.1% vs 2.2%）
富兰克林柯维总部位于美国犹他州盐湖城，是一家专业培训指导企业，面向各类组织与个人提供领导力提升、个人效能成长与业务执行领域的培训及评估服务。公司由富兰克林奎斯特与柯维领导力中心于1997年合并成立，最为人熟知的产品包括富兰克林柯维规划系统等。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
FC vs STEM — 直观对比
营收规模更大
FC
是对方的1.4倍
$47.1M
营收增速更快
FC
高出8.3%
-15.6%
净利率更高
FC
高出28.8%
-33.9%
两年增速更快
STEM
近两年复合增速
2.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $64.0M | $47.1M |
| 净利润 | $-3.3M | $-16.0M |
| 毛利率 | 75.5% | 48.9% |
| 营业利润率 | -5.7% | -17.7% |
| 净利率 | -5.1% | -33.9% |
| 营收同比 | -7.3% | -15.6% |
| 净利润同比 | -378.5% | 68.8% |
| 每股收益（稀释后） | $-0.27 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCSTEM
| Q4 25 | $64.0M | $47.1M | ||
| Q3 25 | $71.2M | $38.2M | ||
| Q2 25 | $67.1M | $38.4M | ||
| Q1 25 | $59.6M | $32.5M | ||
| Q4 24 | $69.1M | $55.8M | ||
| Q3 24 | $84.1M | $29.3M | ||
| Q2 24 | $73.4M | $34.0M | ||
| Q1 24 | $61.3M | $25.5M |
净利润FCSTEM
| Q4 25 | $-3.3M | $-16.0M | ||
| Q3 25 | $4.4M | $-23.8M | ||
| Q2 25 | $-1.4M | $202.5M | ||
| Q1 25 | $-1.1M | $-25.0M | ||
| Q4 24 | $1.2M | $-51.1M | ||
| Q3 24 | $12.0M | $-148.3M | ||
| Q2 24 | $5.7M | $-582.3M | ||
| Q1 24 | $874.0K | $-72.3M |
毛利率FCSTEM
| Q4 25 | 75.5% | 48.9% | ||
| Q3 25 | 75.5% | 35.5% | ||
| Q2 25 | 76.5% | 33.4% | ||
| Q1 25 | 76.7% | 32.4% | ||
| Q4 24 | 76.3% | -4.4% | ||
| Q3 24 | 78.1% | 21.2% | ||
| Q2 24 | 76.6% | 27.6% | ||
| Q1 24 | 76.4% | -95.0% |
营业利润率FCSTEM
| Q4 25 | -5.7% | -17.7% | ||
| Q3 25 | 11.1% | -33.6% | ||
| Q2 25 | -3.3% | -34.8% | ||
| Q1 25 | -2.4% | -65.0% | ||
| Q4 24 | 2.1% | -84.4% | ||
| Q3 24 | 21.3% | -493.2% | ||
| Q2 24 | 11.4% | -1705.5% | ||
| Q1 24 | 2.4% | -267.0% |
净利率FCSTEM
| Q4 25 | -5.1% | -33.9% | ||
| Q3 25 | 6.1% | -62.2% | ||
| Q2 25 | -2.1% | 527.8% | ||
| Q1 25 | -1.8% | -76.9% | ||
| Q4 24 | 1.7% | -91.6% | ||
| Q3 24 | 14.2% | -506.3% | ||
| Q2 24 | 7.8% | -1712.6% | ||
| Q1 24 | 1.4% | -283.9% |
每股收益（稀释后）FCSTEM
| Q4 25 | $-0.27 | $-4.40 | ||
| Q3 25 | $0.34 | $-2.84 | ||
| Q2 25 | $-0.11 | $-1.79 | ||
| Q1 25 | $-0.08 | $-0.15 | ||
| Q4 24 | $0.09 | $-15.29 | ||
| Q3 24 | $0.89 | $-18.24 | ||
| Q2 24 | $0.43 | $-71.81 | ||
| Q1 24 | $0.06 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $17.5M | $48.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $54.0M | $-249.4M |
| 总资产 | $221.3M | $308.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FCSTEM
| Q4 25 | $17.5M | $48.9M | ||
| Q3 25 | $31.7M | $43.1M | ||
| Q2 25 | $33.7M | $40.8M | ||
| Q1 25 | $40.4M | $58.6M | ||
| Q4 24 | $53.3M | $56.3M | ||
| Q3 24 | $48.7M | $75.4M | ||
| Q2 24 | $36.6M | $89.6M | ||
| Q1 24 | $40.9M | $112.8M |
股东权益FCSTEM
| Q4 25 | $54.0M | $-249.4M | ||
| Q3 25 | $66.9M | $-235.7M | ||
| Q2 25 | $65.6M | $-214.1M | ||
| Q1 25 | $72.5M | $-417.5M | ||
| Q4 24 | $80.6M | $-398.4M | ||
| Q3 24 | $83.1M | $-344.1M | ||
| Q2 24 | $72.2M | $-203.2M | ||
| Q1 24 | $70.8M | $371.6M |
总资产FCSTEM
| Q4 25 | $221.3M | $308.9M | ||
| Q3 25 | $242.9M | $362.6M | ||
| Q2 25 | $218.3M | $379.2M | ||
| Q1 25 | $221.3M | $405.1M | ||
| Q4 24 | $239.9M | $437.4M | ||
| Q3 24 | $261.5M | $537.8M | ||
| Q2 24 | $221.0M | $691.5M | ||
| Q1 24 | $221.9M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.0K | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.6M | — |
| 自由现金流率自由现金流/营收 | -2.5% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.9M | — |
8季度趋势，按日历期对齐
经营现金流FCSTEM
| Q4 25 | $98.0K | $8.2M | ||
| Q3 25 | $9.9M | $11.4M | ||
| Q2 25 | $6.3M | $-21.3M | ||
| Q1 25 | $-1.4M | $8.5M | ||
| Q4 24 | $14.1M | $-14.7M | ||
| Q3 24 | $21.9M | $-9.4M | ||
| Q2 24 | $8.2M | $-11.9M | ||
| Q1 24 | $12.8M | $-621.0K |
自由现金流FCSTEM
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $5.7M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $-2.6M | — | ||
| Q4 24 | $13.1M | — | ||
| Q3 24 | $20.8M | — | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $12.1M | — |
自由现金流率FCSTEM
| Q4 25 | -2.5% | — | ||
| Q3 25 | 8.0% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | -4.4% | — | ||
| Q4 24 | 19.0% | — | ||
| Q3 24 | 24.7% | — | ||
| Q2 24 | 9.9% | — | ||
| Q1 24 | 19.8% | — |
资本支出强度FCSTEM
| Q4 25 | 2.7% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 1.0% | — |
现金转化率FCSTEM
| Q4 25 | — | — | ||
| Q3 25 | 2.27× | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | 11.98× | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 1.43× | — | ||
| Q1 24 | 14.62× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
